ArticleCureus2024
Comparative Analysis of Classification of Neonatal Bilirubin by Using Various Machine Learning Approaches.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Neonatal jaundice poses significant risks to newborn health, necessitating early detection and management. Machine learning (ML) offers promising avenues for improving classification and monitoring, potentially revolutionizing neonatal care. Materials and methods A comparative analysis was conducted using various ML algorithms to classify neonatal bilirubin levels. Data were collected from neonatal images, and algorithms were trained and tested using standard methodologies. Performance metrics, including accuracy, precision, and recall, were evaluated to assess algorithm effectiveness. Results The Nu-Support Vector Classification (NuSVC) model emerged as the most effective, achieving a testing accuracy of 62.50%, with precision and recall rates of 61.90% and 56.52%, respectively. While variability existed among algorithms, these results highlight NuSVC's potential for clinical application in neonatal jaundice screening. Conclusion ML holds promise for improving neonatal jaundice detection and management. The findings suggest that the NuSVC algorithm can enhance screening accuracy, potentially mitigating risks associated with untreated neonatal jaundice. Future research should focus on refining models for broader clinical applicability and integrating ML into decision support systems to improve neonatal care globally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.